دورية أكاديمية
أعرض في EDS

Adding Short to Left Gastric Artery Embolization for the Treatment of Obesity: Safety and Effectiveness.

التفاصيل البيبلوغرافية
العنوان: Adding Short to Left Gastric Artery Embolization for the Treatment of Obesity: Safety and Effectiveness.
المؤلفون: di Giuseppe R; Department of Radiology, Hôpital Beaujon, APHP.Nord, Université Paris Cité, Clichy, France., Hansel B; Department of Endocrinology-Diabetology-Nutrition, Hôpital Bichat, APHP.Nord, Université Paris Cité, Paris, France., Puyraimond Zemmour J; Department of Endocrinology-Diabetology-Nutrition, Hôpital Bichat, APHP.Nord, Université Paris Cité, Paris, France., Vilgrain V; Department of Radiology, Hôpital Beaujon, APHP.Nord, Université Paris Cité, Clichy, France., Ronot M; Department of Radiology, Hôpital Beaujon, APHP.Nord, Université Paris Cité, Clichy, France., Garzelli L; Department of Radiology, Hôpital Beaujon, APHP.Nord, Université Paris Cité, Clichy, France. lorenzo.garzelli@aphp.fr.; Department of Medical Imaging, Cayenne Hospital Centre, Cayenne, French Guiana. lorenzo.garzelli@aphp.fr.
المصدر: Cardiovascular and interventional radiology [Cardiovasc Intervent Radiol] 2024 Jul; Vol. 47 (7), pp. 945-952. Date of Electronic Publication: 2024 Apr 23.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Verlag Country of Publication: United States NLM ID: 8003538 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-086X (Electronic) Linking ISSN: 01741551 NLM ISO Abbreviation: Cardiovasc Intervent Radiol Subsets: MEDLINE
أسماء مطبوعة: Publication: New York Ny : Springer Verlag
Original Publication: [Berlin, New York] Springer International.
مواضيع طبية MeSH: Embolization, Therapeutic*/methods , Gastric Artery* , Obesity*/therapy , Obesity*/complications , Weight Loss*, Humans ; Female ; Retrospective Studies ; Male ; Middle Aged ; Adult ; Aged ; Treatment Outcome ; Microspheres
مستخلص: Purpose: This study assessed the safety and effectiveness of a technical modification that involves adding short gastric artery (SGA) embolization to left gastric artery (LGA) embolization.
Material and Methods: This retrospective single-center study analyzed twenty obese patients (median age of 53.5 (30-73)) who were not eligible for bariatric surgery and underwent bariatric embolization with 300-500-µm microspheres in addition to a lifestyle counseling program between March 2021 and July 2022. Eight patients had LGA + SGA embolization, and twelve had LGA embolization alone. The primary outcome measure was total body weight loss (TBWL) at 6 months in the SGA + LGA and the LGA-only cohorts. Safety was assessed, defined as the 30-day adverse events rate according to the SIR classification.
Results: The mean 6-month post-embolization TBWL in the SGA + LGA cohort was 7.3 kg (95%CI 2.1-12.4; p = .01) and 4.1 kg (95%CI 0.4-8.6; p = 0.034) in the LGA-only cohort (mean difference - 3.1 kg ± 2.8; 95%CI (- 9.1-2.8); p = .28). The mean 6-month post-embolization TBWL in the entire cohort was 5.3 kg (p < .01). The rate of complications was similar between the two groups.
Conclusion: Combined SGA and LGA embolization is safe and effective to treat obesity. Larger studies are needed to determine whether SGA + LGA embolization results in more significant weight loss than LGA embolization alone.
(© 2024. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).)
References: Reddy VY, Neužil P, Musikantow D, et al. Transcatheter bariatric embolotherapy for weight reduction in obesity. J Am Coll Cardiol. 2020;76(20):2305–17. (PMID: 10.1016/j.jacc.2020.09.55033183504)
Weiss CR, Abiola GO, Fischman AM, et al. Bariatric embolization of arteries for the treatment of obesity (BEAT Obesity) trial: results at 1 year. Radiology. 2019;291(3):792–800. (PMID: 10.1148/radiol.201918235430938624)
Loukas M, Wartmann CT, Louis RG Jr, et al. The clinical anatomy of the posterior gastric artery revisited. Surg Radiol Anat. 2007;29(5):361–6. (PMID: 10.1007/s00276-007-0222-417563830)
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–6. (PMID: 10.1007/s00270-017-1703-428584945)
Vanderbecq Q, Grégory J, Dana J, et al. Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia. Diagn Interv Imaging. 2022;104(3):123–32. (PMID: 10.1016/j.diii.2022.10.01336805801)
Pachev A, Raynaud L, Paulatto L, et al. Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma. Eur Radiol. 2021;31(5):3267–75. (PMID: 10.1007/s00330-020-07404-533123789)
Levigard RB, Serrão H, Castro C, et al. Bariatric embolization in the treatment of patients with a body mass index between 30 and 39.9 kg/m(2) (Obesity Class I and II) and metabolic syndrome, a pilot study. Cardiovasc Intervent Radiol. 2021;44(4):598–606. (PMID: 10.1007/s00270-021-02776-733527186)
Bai ZB, Qin YL, Deng G, Zhao GF, Zhong BY, Teng GJ. Bariatric embolization of the left gastric arteries for the treatment of obesity: 9-month data in 5 patients. Obes Surg. 2018;28(4):907–15. (PMID: 10.1007/s11695-017-2979-929063494)
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002. (PMID: 10.1056/NEJMoa203218333567185)
فهرسة مساهمة: Keywords: Bariatric medicine; Embolization, Therapeutic; Obesity; Weight loss
تواريخ الأحداث: Date Created: 20240423 Date Completed: 20240711 Latest Revision: 20240711
رمز التحديث: 20240711
DOI: 10.1007/s00270-024-03702-3
PMID: 38653810
قاعدة البيانات: MEDLINE
الوصف
تدمد:1432-086X
DOI:10.1007/s00270-024-03702-3